Statera BioPharma's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Statera BioPharma is scheduled to report earnings on August 14, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21
Income Statement	-
Total Revenue	$ 670.47K	-	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -169.35K	-	$ -353.67K	$ -372.39K	$ -115.93K
EBIT	$ -3.36M	-	$ -6.61M	$ -9.58M	$ -9.64M
EBITDA	$ -3.17M	$ 131.09K	$ -6.49M	$ -9.47M	$ -9.64M
Net Income Common Stockholders	$ -3.35M	$ -3.49M	$ -7.76M	$ -77.24M	$ -12.72M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 506.10K	$ 716.86K	$ 330.57K	$ 1.98M	$ 9.45M
Total Assets	$ 12.75M	$ 13.54M	$ 13.51M	$ 21.17M	$ 98.04M
Total Debt	$ 7.41M	$ 7.55M	$ 7.12M	$ 16.26M	$ 16.74M
Net Debt	$ 6.90M	$ 6.84M	$ 6.79M	$ 14.28M	$ 7.29M
Total Liabilities	$ 22.92M	$ 20.46M	$ 15.94M	$ 22.68M	$ 23.84M
Stockholders Equity	$ -10.24M	$ -6.99M	$ -2.49M	$ -1.57M	$ 74.12M
Cash Flow	-
Free Cash Flow	$ -801.52K	$ -168.51K	$ -3.77M	$ -8.23M	-
Operating Cash Flow	$ -801.52K	$ -168.51K	$ -3.76M	$ -8.13M	-
Investing Cash Flow	-	-	$ -6.45K	$ -96.91K	-
Financing Cash Flow	$ 711.65K	$ 500.13K	$ -2.90M	$ 858.95K	-

Currency in USD

Statera BioPharma Earnings and Revenue History

Income Statement >

Statera BioPharma Debt to Assets

Balance Sheet >

Statera BioPharma Cash Flow

Cash Flow >

Statera BioPharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing